Cite
HARVARD Citation
Brun, M. et al. (2022). Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. Journal of internal medicine. pp. 477-491. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Brun, M. et al. (2022). Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. Journal of internal medicine. pp. 477-491. [Online].